secwatch.observer — SEC 8-K summary
======================================

Issuer:     Twist Bioscience Corp (TWST)
CIK:        0001581280
Form:       8-K
Filed at:   2021-12-02T23:59:59+00:00
Accession:  0001193125-21-346678
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Twist Bioscience completes acquisition of Abveris (AbX Biologics)
-----------------------------------------------------------------

- Acquisition closed December 1, 2021, under merger agreement dated November 19, 2021.
- Twist issued stock consideration; entered Registration Rights Agreement to register resale of those shares.
- No financial terms (deal value, premium, or expected impact) disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1581280/000119312521346678/0001193125-21-346678-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1581280/000119312521346678/d150633d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-346678

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer